Tech Company Inital Public Offerings

CureVac IPO

Headquartered in Tübingen, CureVac went public.

Transaction Overview

Company Name
Announced On
8/13/2020
Transaction Type
IPO
Amount
$213,280,000
Proceeds Purpose
We currently intend to use the net proceeds from the offering and the concurrent private placement, together with cash and cash equivalents on hand as follows: [i] to fund the Company's mRNA vaccine program against SARS-CoV-2 through the completion of Phase 3; [ii] to fund the expansion of the Company's short term manufacturing capabilities; [iii] to advance the Company's lead oncology program, CV8102, through the completion of the Phase 2 clinical trial; [iv] to advance the Company's vaccine program, CV7202 in rabies through the completion of the Phase 2 clinical trial; [v] to invest in further development of the Company's mRNA technology platform and to advance the development of other preclinical and clinical programs; and [vi] the remainder for working capital and general corporate purposes.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
15 Paul-Ehrlich-Strasse
Tübingen, 72076
Germany
Email Address
Overview
CureVac (Nasdaq: CVAC) is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.
Profile
CureVac LinkedIn Company Profile
Social Media
CureVac Company Twitter Account
Company News
CureVac News
Facebook
CureVac on Facebook
YouTube
CureVac on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Daniel Menichella
  Daniel Menichella LinkedIn Profile  Daniel Menichella Twitter Account  Daniel Menichella News  Daniel Menichella on Facebook
Chief Financial Officer
Pierre Kemula
  Pierre Kemula LinkedIn Profile  Pierre Kemula Twitter Account  Pierre Kemula News  Pierre Kemula on Facebook
Chief Operating Officer
Franz-Werner Haas
  Franz-Werner Haas LinkedIn Profile  Franz-Werner Haas Twitter Account  Franz-Werner Haas News  Franz-Werner Haas on Facebook
Chief Scientific Officer
Mariola Fotin-Mleczek
  Mariola Fotin-Mleczek LinkedIn Profile  Mariola Fotin-Mleczek Twitter Account  Mariola Fotin-Mleczek News  Mariola Fotin-Mleczek on Facebook
Founder
Ingmar Hoerr
  Ingmar Hoerr LinkedIn Profile  Ingmar Hoerr Twitter Account  Ingmar Hoerr News  Ingmar Hoerr on Facebook
VP - Product Management
Florian Mülbe
  Florian Mülbe LinkedIn Profile  Florian Mülbe Twitter Account  Florian Mülbe News  Florian Mülbe on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/13/2020: Reify Health venture capital transaction
Next: 8/13/2020: iRestify venture capital transaction

 

Share this article

 


About Database of VC Transactions

We report on tech company VC transactions. All VC database entries reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary